Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A provider-guided plan can help patients set realistic protein goals, reduce muscle-loss risk, monitor side effects, and adjust treatment based on symptoms, labs, and progress
3, 2022, pp
Telehealth companies increase access to people living in remote areas or those less able to leave the house
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 clinical trial protocols (investigational only): Starting dose : 0.5 mg weekly subcutaneous injection Escalation : Gradual increase over 12-24 weeks to target dose (up to 12 mg) Target doses tested : 1, 4, 8, and 12 mg weekly Escalation rationale : Extended 24-week escalation for higher doses reduces GI side effects compared to faster 12-week escalation No commercial formulation exists
